Fig. 1From: Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational studyLongitudinal measurements of RVEDV over 18 months. There were significant changes in RVEDV over time (p = 0.004). By Sidak-adjusted pairwise comparisons with the baseline, the mean RVEDV showed a small but significant increase at 6 months (p = 0.002), that was no longer significant at 18 months (p = 0.82). Data shown as mean and 95% confidence intervals (vertical bars)Back to article page